Drug Shortage Report for IBAVYR
| Report ID | 174659 |
| Drug Identification Number | 02425890 |
| Brand name | IBAVYR |
| Common or Proper name | IBAVYR |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | DORMANT |
| Active Ingredient(s) | RIBAVIRIN |
| Strength(s) | 400MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | J05AP |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-14 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-08-04 |
| Company comments | See discontinuation report 182029 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2023-08-04 | French | Compare |
| v4 | 2023-08-04 | English | Compare |
| v3 | 2022-11-15 | English | Compare |
| v2 | 2022-11-14 | French | Compare |
| v1 | 2022-11-14 | English | Compare |
Showing 1 to 5 of 5